These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 11544399)

  • 1. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].
    Buitrón García R; Romero Cabello R; Cruz Talonia F; Bonifaz A; Zarama Marquez F
    Ginecol Obstet Mex; 2002 Sep; 70():431-6. PubMed ID: 12448051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
    Buscemi L; Arechavala A; Negroni R
    Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation, identification and serotyping of yeasts obtained from the vaginal fluid in patients with clinical vaginitis].
    Mendoza M; González I; Bellorin EJ; Salazar W; Mendoza L; Zambrano EA; de Albornoz MC
    Invest Clin; 1999 Mar; 40(1):25-36. PubMed ID: 10198559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
    al-Rawi N; Kavanagh K
    Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Candida species in vaginal samples in a clinical laboratory setting.
    Trama JP; Adelson ME; Raphaelli I; Stemmer SM; Mordechai E
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):63-7. PubMed ID: 16011995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
    Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
    APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status.
    Goswami R; Dadhwal V; Tejaswi S; Datta K; Paul A; Haricharan RN; Banerjee U; Kochupillai NP
    J Infect; 2000 Sep; 41(2):162-6. PubMed ID: 11023762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE.
    Hamad M; Kazandji N; Awadallah S; Allam H
    Mycoses; 2014 Mar; 57(3):184-90. PubMed ID: 24102778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyotyping of Candida albicans and Candida glabrata isolates from recurrent vaginal infections by pulsed-field gel electrophoresis.
    Fodor E; Dósa E; Nagy A; Nagy E; Ferenczy L
    Acta Microbiol Immunol Hung; 2002; 49(1):59-68. PubMed ID: 12073826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The distribution of Candida species isolated from vaginal discharge].
    Cengiz AT; Ataoğlu H; Cengiz L; Seyhun A; Gülmezoğlu M; Kiliç H
    Mikrobiyol Bul; 1989 Oct; 23(4):275-83. PubMed ID: 2488934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of Candida species in vaginal specimens and evaluation of CHROMagar Candida medium].
    Gültekin B; Yazici V; Aydin N
    Mikrobiyol Bul; 2005 Jul; 39(3):319-24. PubMed ID: 16358491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.
    Ahmad A; Khan AU
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):68-71. PubMed ID: 19261369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.